Two cases of serious rhabdomyolysis during linezolid treatment

Autor:	Ingrid Pretsch, Eva Past, Ulla Porsche, Uta C. Hoppe, Jan Marco Kern, Arno M. Lechner
Rok vydání:	2017
Předmět:	Male Methicillin-Resistant Staphylococcus aureus 0301 basic medicine Microbiology (medical) medicine.medical_specialty medicine.drug_class 030106 microbiology Antibiotics India MRSA sepsis Case Report Mrsa sepsis medicine.disease_cause Rhabdomyolysis Diagnosis Differential 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine medicine Humans In patient 030212 general & internal medicine Intensive care medicine Aged business.industry Linezolid MRSA pneumonia General Medicine Middle Aged Staphylococcal Infections biochemical phenomena metabolism and nutrition bacterial infections and mycoses medicine.disease Anti-Bacterial Agents Pneumonia Treatment Outcome Infectious Diseases chemistry Staphylococcus aureus Austria Female business Blood stream
Zdroj:	Infection
ISSN:	1439-0973 0300-8126
Popis:	Linezolid is an oxazolidinone antibiotic with activity against gram-positive organisms, particularly methicillin-resistant Staphylococcus aureus (MRSA). To the best of our knowledge, there are only two case reports on rhabdomyolysis in patients treated with linezolid. Here, we describe two cases of serious rhabdomyolysis: one in a patient with septic community-acquired (CA)-MRSA pneumonia and a second case in a patient with suspected catheter-related blood stream infection.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c9dd785d92b9d45a7132c18a2489360 https://doi.org/10.1007/s15010-016-0978-8 Zobrazit plný text záznamu Full text from SpringerLink